![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 29, 2016 11:50:26 AM
The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has bounced beautifully off of double bottom support at $240 on the daily chart. Today it traded as high as $254.70, just two days after hitting $240.00.
Investors are wondering if it is safe to buy the $IBB? The short answer is... no. This is why...
There is a major concern on the daily chart of the biotech ETF IBB. Notice the confirmed break down that took place when the IBB broke through the upsloping trend line. Once confirmed, a retrace into that trend line (like we are seeing today) is almost always a heavy shorting opportunity. That means the IBB may fall sharply as early as next week. If the IBB is falling hard, you can bet the market is dropping sharply. This should be a major concern to not only biotech investors but all investors in the stock market. Note the chart below...
Chart: https://verifiedinvesting.com/uploads/files/IBB06.29.2016.JPG
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM